General MedicationsINJECTIONGeneric
DURABOLIN
NANDROLONE PHENPROPIONATE
Standard Dose
25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DURABOLIN is listed in Drugs@FDA under application 011891 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NANDROLONE PHENPROPIONATE Form and strength INJECTABLE;INJECTION - 25MG/ML Sponsor ORGANON USA INC Submission history Latest submission status date: 1994-02-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview DURABOLIN is listed in Drugs@FDA under application 011891 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NANDROLONE PHENPROPIONATE Form and strength INJECTABLE;INJECTION - 25MG/ML Sponsor ORGANON USA INC Submission history Latest submission status date: 1994-02-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.